2023
|
Invention
|
Use of dianhydrogalactitol in treating ependymoma. Compositions and methods for treating ependymo... |
|
Invention
|
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas.
A method for treatin... |
2022
|
Invention
|
Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease... |
2021
|
Invention
|
Methods for treating a cancer resistant to at least one tyrosine kinase inhibitor.
Methods and c... |
2018
|
Invention
|
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas. Methods for treating ... |
|
Invention
|
Use of dianhydrogalactitol or analogs and derivatives in combination with vegf inhibitors to trea... |
|
Invention
|
Use of dianhydrogalactitol or analogs and derivatives in combination with a p53 modulator or a pa... |
2016
|
Invention
|
Methods for analysis and resolution of preparations of dianhydrogalactitol and derivatives or ana... |
|
Invention
|
Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central n... |
|
Invention
|
Use of dianhydrogalactitol and derivatives thereof in the treatment of glioblastoma, lung cancer,... |
2015
|
Invention
|
Use of dianhydrogalactitol and analogs and derivatives thereof, together with radiation, to treat... |
|
Invention
|
Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds i... |
|
Invention
|
Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-contai... |
|
Invention
|
Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant gliom... |
2013
|
Invention
|
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic po... |
|
Invention
|
Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat ... |
|
Invention
|
Analytical methods for analyzing and determining impurities in dianhydrogalactitol. An improved a... |
2011
|
Invention
|
Methods to improve the therapeutic benefit of suboptimally administered chemical compounds includ... |